Mobile

A Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin and Sitagliptin The...

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-004819-40

A Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin and Sitagliptin Therapy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

In subjects with T2DM who have inadequate glycemic control on maximally or near-maximally effective doses of metformin and on sitagliptin, after 26 weeks of treatment: •To assess the effect of canagliflozin relative to placebo on HbA1c •To assess the safety and tolerability of canagliflozin

Critère d'inclusion

  • Type 2 Diabetes Mellitus With Inadequate Glycemic Control

Liens